Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-24

FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a generic combination tablet of olmesartan medoxomil and hydrochlorothiazide from Alembic Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olmesartan Medoxomil and Hydrochlorothiazide (olmesartan medoxomil; hydrochlorothiazide)

Snippet

ORIG AP for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE)